Global Peptide Building Block Market Anticipated to Reach US$ 698.44 Million by 2032

According to a recent market study published by Growth Market Reports, titled, “Global Peptide Building Block Market By Type, By Application, By Sales Channel, and By Region: Size, Share, Trends and Opportunity Analysis, 2017-2032”, the market was valued at US$ 443.81 Million in 2023 and is anticipated to expand at a growth rate of 6.4% by 2032.

Peptide building blocks are the individual units that make up peptides, which are short chains of amino acids. Amino acids are organic compounds consisting of an amino group (-NH2), a carboxyl group (-COOH), and a side chain specific to each amino acid. Peptide building blocks are the 20 standard amino acids, each with its own unique side chain. These amino acids link together through peptide bonds, forming peptides and proteins. These building blocks can be chemically synthesized or obtained through biological processes, and they serve as the fundamental components for constructing a wide variety of peptides with diverse functions and structures.

Get Sample Report @ https://growthmarketreports.com/request-sample/6698

The global peptide building block market has been segmented in terms of type, application and sales channel. in terms of type, the global peptide building block market is segmented into 2-Cl-(Trt)-Cl resin, 3-tritylmercapto propionicacid, 9-fluorenylmethanol, BOP-reagent, wang resins, and others. Based on application market is fragmented into chemistry experiment, industrial, and others. In terms of sales channel the market is segmented into online and offline. Considering regions, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The COVID-19 pandemic presented both challenges and opportunities in the peptide building block market. The pandemic led to disruptions in global supply chains due to lockdowns, travel restrictions, and closures of manufacturing facilities. This could have affected the availability of raw materials required for the synthesis of peptide building blocks. Despite the challenges, the pandemic also presented opportunities for innovation in the peptide building blocks market. For example, there may have been increased interest in developing peptides with antiviral properties or peptides that can modulate the immune response.

Key Takeaways from the Study:

• Players in the global peptide building block market include GenScript, AnaSpec, Merck, PeptaNova GmbH, IRIS BIOTECH GMBH, GRACE, AAPPTec, LLC

• Based on type, the peptide building block market is segmented into 2-Cl-(Trt)-Cl resin, 3-tritylmercapto propionicacid, 9-fluorenylmethanol, BOP-reagent, Wang resins, and others. The 2-Cl-(Trt)-Cl resin segment is anticipated to hold a market share of 3.32% in 2032, as it is a widely used and a popular resin in the peptide building block for its high reactivity and versatility.

• Based on application, the peptide building block market is segmented into chemistry experiment, industrial, and others. The chemistry experiment segment is anticipated to hold a market share of 33.73% in 2032, as it is expected to witness significant growth driven by the increasing adoption of peptide building blocks in research and development. The segment is expected to be driven by the growing demand for peptide-based pharmaceuticals and therapeutics as well as the increasing use of peptide building blocks in academic and research institutions.

• On the basis of sales channel, the peptide building block market is segmented into online and offline. The Online segment is expected to hold a market share of 20.10% in 2032, as it is a more accessible and cost-effective way for consumers to purchase peptide building blocks, including researchers, pharmaceutical companies, and academic institutions. The Online segment allows for greater flexibility and convenience, enabling customers to browse and purchase products from a wide range of suppliers, as well as access detailed product information and technical support. In addition, online sales channels often offer lower prices due to reduced overhead costs, making them an attractive option for budget-conscious customers.

• Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa (MEA). The North America is anticipated to register a CAGR of 5.64% during the forecast period. Market players in the region are investing to develop innovative peptide building block products with enhanced properties and functionalities. For instance, on January 23, 2024, Merck & Co., a US-based pharmaceutical company invested USD 220 million biobucks to develop macrocyclic peptide candidates against oncology target.

Key Developments

• In February 2023, BACHEM, a biotechnology company, has developed a new creative strategy to large-scale peptide manufacturing. Peptide manufacturing made smarter by automating and digitalizing SPPS. The Molecular Hiving technology to produce shorter peptides without toxic solvents, with more efficient scale-up and improved process controls.

Report Scope:

Target Audience:

• Supply-side: Manufacturers, End-users/Applications

• Regulatory Side: Concerned government authorities, and other approved regulatory bodies.

  • • United States Food and Drug Administration (FDA)

    • European Union (EU)

    • Medicines and Healthcare Products Regulatory Agency (MHRA)

    • National Research Foundation of Korea (NRF)